Results 131 to 140 of about 18,928 (205)

Retrospective observational analysis of prasugrel dosage afterpercutaneous coronary intervention using the Clinical Deep DataAccumulation System database. [PDF]

Glob Health Med
Hiroi Y, Shimizu Y, Uemura Y, Kajikawa I, Matsuo R, Yamamoto M, Hara H, Kodera S, Kiyosue A, Mizuno Y, Miyamoto Y, Nakayama M, Matoba T, Ishii M, Tsujita K, Sakata Y, Kabutoya T, Kario K, Imai Y, Makimoto H, Kohro T, Akashi N, Fujita H, Nagai R, Clidas Research Group.   +24 more
europepmc   +1 more source

Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]

Ther Clin Risk Manag
Li Y, Gong J, Liu N.
europepmc   +1 more source

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience [PDF]

, 2013
Artur Dziewierz, Dariusz Dudek, Jacek S. Dubiel, Paweł Kleczyński, Tomasz Rakowski, Zbigniew Siudak   +5 more
core   +2 more sources

Redefining Dual Antiplatelet Strategies After Acute Coronary Syndrome: Insights from Recent RCTs. [PDF]

J Clin Med
He M, Magdy J, Aziz M, Tan J, Das A, Wheatcroft SB, Bulluck H.   +6 more
europepmc   +1 more source

Evaluation of the Anti-inflammatory Effects of Ticagrelor and Prasugrel as Add-On Therapy to Aspirin in Diabetic Patients Post-percutaneous Coronary Intervention. [PDF]

Cureus
Panigrahy A, Mekala P, Pingali U, Vs B.
europepmc   +1 more source

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026. [PDF]

Cardiovasc Interv Ther
Ozaki Y, Tobe A, Onuma Y, Miyashita K, Kobayashi Y, Amano T, Yamaji K, Ishii H, Muramatsu T, Ismail TF, Kohsaka S, Nakagawa Y, Morino Y, Uemura S, Tsujita K, Shinke T, Ako J, Yajima J, Maekawa Y, Shite J, Igarashi Y, Shiode N, Okamura A, Ogawa T, Yamaguchi J, Tamura T, Tsuji T, Hayashida K, Sugano T, Okura H, Okayama H, Kawaguchi K, Zen K, Takahashi S, Nakazato K, Suematsu N, Hironaga K, Matoba T, Iida O, Ishihara M, Ohta M, Harada M, Ozaki R, Izawa H, Murohara T, Ueno T, Nakamura M, Ikari Y, Serruys PW, Kozuma K, Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT).   +50 more
europepmc   +1 more source

ATLANTIC: another reason to investigate the disconnect between stent thrombosis and mortality? [PDF]

, 2015
Aradi, Dániel, Sibbing, Dirk
core   +1 more source

Adjusting Antiplatelet Therapy Using P2Y₁₂ Reaction Units in Endovascular Treatment of Unruptured Intracranial Aneurysms. [PDF]

Stroke Vasc Interv Neurol
Moon E, Song Y, Park JC, Kwon B, Park W, Ahn JS, Lee DH, Suh DC.   +7 more
europepmc   +1 more source

Bridging Technique with a Stent Retriever for Iatrogenic Internal Carotid Artery Occlusion during Coil Embolization of a Ruptured Aneurysm. [PDF]

J Neuroendovasc Ther
Matsuishi M, Horio Y, Senju K, Yoshinaga S, Takemoto K, Abe H.   +5 more
europepmc   +1 more source

Sex-Based Differences in the Effect of Short Dual Antiplatelet Therapy Followed by Prasugrel Monotherapy in High-Bleeding-Risk Patients After Percutaneous Coronary Intervention. [PDF]

Circ Rep
Kogame N, Nakagawa Y, Kozuma K, Iijima R, Tsutsui A, Murakami Y, Fukuzawa M, Abe S, Kato G, Nakamura M.   +9 more
europepmc   +1 more source